Saving Lives on Campuses Act of 2026
- Sponsor
- Rep. De La Cruz, Monica [R-TX-15]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Apr 27, 2026
Bottom line
This bill mandates the widespread availability of opioid overdose rescue kits and associated training at public colleges and universities receiving federal aid to combat opioid-related deaths on campuses.
What it actually does
This bill mandates that public institutions of higher education receiving federal funds must make opioid overdose rescue kits available across their campuses. These kits must be placed in various facilities like classrooms, libraries, dorms, and carried by campus emergency medical services personnel. Institutions are also required to replace used or expired kits, list their locations, and provide training on their use during student orientation programs.
Proponents argue
Supporters argue that this bill is a vital public health measure that will save lives by providing immediate access to life-saving naloxone on college campuses, a demographic increasingly affected by the opioid crisis. They contend that proactive measures are necessary to mitigate overdose fatalities and ensure student safety.
Opponents contend
Potential opponents might raise concerns about the bill constituting an unfunded mandate, placing significant financial and logistical burdens on public institutions without providing dedicated federal funding. Some might also argue about the effectiveness of widespread public access without more comprehensive medical oversight or express concerns about normalizing drug use.
The bill is exceptionally short and clearly written, allowing for a very quick and straightforward evaluation by any interested reader.
Section 2(a) and 2(b)
Mandatory Opioid Overdose Rescue Kits at Public Institutions
Within one year of the bill's enactment, the Secretary of Education, in consultation with the Secretary of Health and Human Services, must require all public institutions of higher education that receive federal funding to make opioid overdose rescue kits available. These kits must be placed in all classroom facilities, libraries, laboratory facilities, dormitories (including dining facilities), and other facilities customarily used by the institution for instructional, research, or housing purposes. Where automated external defibrillators (AEDs) are present, the kits should be placed nearby if feasible, and campus emergency medical services personnel must also carry them.
Supporters argue
Supporters argue this provision directly addresses the opioid crisis by ensuring immediate access to life-saving naloxone, thereby reducing overdose fatalities on college campuses where young adults are at a heightened risk. They emphasize that rapid intervention is crucial for survival.
Critics contend
Critics might argue this provision constitutes an unfunded mandate, placing an undue financial and logistical burden on institutions, especially smaller ones, without providing federal funding for compliance. They may also question the efficacy of widespread, unsupervised access without more robust medical infrastructure.
Tradeoffs
This provision balances the public health imperative of saving lives by providing immediate access to overdose reversal medication against the potential financial and administrative costs for educational institutions, which may need to reallocate existing resources.
Section 2(c)
Ongoing Maintenance, Listing, and Training Requirements
In addition to making kits available, each institution must establish procedures to replace used or expired opioid overdose rescue kits as necessary. They are also required to maintain and make available a list of all kit locations through the institution's health center or campus emergency medical services. Furthermore, institutions must provide training regarding the use and location of these kits during every student orientation program they conduct.
This subsection defines an 'opioid overdose rescue kit' as a kit labeled 'Overdose Rescue Kit--Naloxone Nasal Spray' or other HHS-approved language, and explicitly states it must include Narcan, Naloxone, or another FDA-approved medication that negates or neutralizes the pharmacological effects of an opioid.
Section 2(d)(2)
Why it matters:Placing definitions at the end of a section is standard legislative practice to ensure clarity and precision in the bill's terms without interrupting the flow of the main policy directives.
Case for: This precise definition ensures that institutions procure and deploy medically effective and clearly identifiable medications, preventing the acquisition of ineffective or improperly labeled products and maintaining a high standard for life-saving interventions.
Case against: No strong case against a clear definition is typically raised, though some might argue that overly specific definitions could limit flexibility for future medical advancements or alternative effective treatments if the list of approved medications is not regularly updated by HHS.
Estimated impact: Ensures consistency and efficacy of life-saving tools across all affected campuses by standardizing the contents and labeling of the required kits.